These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 37886012)

  • 1. Impact of senolytic treatment on immunity, aging, and disease.
    Lorenzo EC; Torrance BL; Haynes L
    Front Aging; 2023; 4():1161799. PubMed ID: 37886012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senolytic elimination of senescent macrophages restores muscle stem cell function in severely dystrophic muscle.
    Liu L; Yue X; Sun Z; Hambright WS; Feng Q; Cui Y; Huard J; Robbins PD; Wang Z; Mu X
    Aging (Albany NY); 2022 Sep; 14(19):7650-7661. PubMed ID: 36084954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promises and challenges of senolytics in skin regeneration, pathology and ageing.
    Pils V; Ring N; Valdivieso K; Lämmermann I; Gruber F; Schosserer M; Grillari J; Ogrodnik M
    Mech Ageing Dev; 2021 Dec; 200():111588. PubMed ID: 34678388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice.
    Fielder E; Wan T; Alimohammadiha G; Ishaq A; Low E; Weigand BM; Kelly G; Parker C; Griffin B; Jurk D; Korolchuk VI; von Zglinicki T; Miwa S
    Elife; 2022 May; 11():. PubMed ID: 35507395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
    Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
    EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration.
    Richardson M; Richardson DR
    Mol Pharmacol; 2024 Jan; 105(2):64-74. PubMed ID: 38164616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis.
    Xing X; Tang Q; Zou J; Huang H; Yang J; Gao X; Xu X; Ma S; Li M; Liang C; Tan L; Liao L; Tian W
    Acta Biomater; 2023 Feb; 157():352-366. PubMed ID: 36470392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials.
    Romashkan S; Chang H; Hadley EC
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1144-1152. PubMed ID: 33528569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senolytic treatment with dasatinib and quercetin does not improve overall influenza responses in aged mice.
    Torrance BL; Cadar AN; Martin DE; Panier HA; Lorenzo EC; Bartley JM; Xu M; Haynes L
    Front Aging; 2023; 4():1212750. PubMed ID: 37396956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the molecular mechanism of quercetin and dasatinib combination as senolytic in alleviating age-related and kidney diseases.
    Alharbi KS; Afzal O; Altamimi ASA; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Makeen HA; Albratty M
    J Food Biochem; 2022 Dec; 46(12):e14471. PubMed ID: 36268851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ageing immune system as a potential target of senolytics.
    Du PY; Gandhi A; Bawa M; Gromala J
    Oxf Open Immunol; 2023; 4(1):iqad004. PubMed ID: 37255929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
    Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
    EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for late phase preclinical and early clinical trials of senolytics.
    Wissler Gerdes EO; Misra A; Netto JME; Tchkonia T; Kirkland JL
    Mech Ageing Dev; 2021 Dec; 200():111591. PubMed ID: 34699859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senolytics: Eliminating Senescent Cells and Alleviating Intervertebral Disc Degeneration.
    Wu Y; Shen S; Shi Y; Tian N; Zhou Y; Zhang X
    Front Bioeng Biotechnol; 2022; 10():823945. PubMed ID: 35309994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senolytic drugs: from discovery to translation.
    Kirkland JL; Tchkonia T
    J Intern Med; 2020 Nov; 288(5):518-536. PubMed ID: 32686219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
    Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A guide to senolytic intervention in neurodegenerative disease.
    Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
    Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications.
    Chandrakar L; Ambatwar R; Khatik GL
    Curr Top Med Chem; 2024; 24(2):157-178. PubMed ID: 38037999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cellular senescence in metabolic disease.
    Palmer AK; Tchkonia T; Kirkland JL
    Mol Metab; 2022 Dec; 66():101601. PubMed ID: 36116755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics procedure for investigating senolytic (anti-aging) agents: A digital signal processing technique.
    Nwankwo N; Okafor I
    Aging Med (Milton); 2023 Dec; 6(4):338-346. PubMed ID: 38239718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.